Literature DB >> 16466541

Familial risks in testicular cancer as aetiological clues.

Kari Hemminki1, Bowang Chen.   

Abstract

We used the nationwide Swedish Family-Cancer Database to analyse the risk for testicular cancer in offspring through parental and sibling probands. Among 0 to 70-year-old offspring, 4,586 patients had testicular cancer. Standardized incidence ratios for familial risk were 3.8-fold when a father and 7.6-fold when a brother had testicular cancer. Testicular cancer was associated with leukaemia, distal colon and kidney cancer, melanoma, connective tissue tumours and lung cancer in families. Non-seminoma was associated with maternal lung cancer but the risk was highest for the late-onset cases, providing no support to the theory of the in utero effect of maternal smoking on the son's risk of testicular cancer. However, the theory cannot be excluded but should be taken up for study when further data are available on maternal smoking. The high familial risk may be the product of shared childhood environment and heritable causes.

Entities:  

Mesh:

Year:  2006        PMID: 16466541     DOI: 10.1111/j.1365-2605.2005.00599.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  34 in total

1.  Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.

Authors:  Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

2.  Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee.

Authors:  Jonathan Richenberg; Jane Belfield; Parvati Ramchandani; Laurence Rocher; Simon Freeman; Athina C Tsili; Faye Cuthbert; Michal Studniarek; Michele Bertolotto; Ahmet Tuncay Turgut; Vikram Dogra; Lorenzo E Derchi
Journal:  Eur Radiol       Date:  2014-10-15       Impact factor: 5.315

3.  Cancer in first-degree relatives and risk of testicular cancer in Denmark.

Authors:  Rikke Baastrup Nordsborg; Jaymie R Meliker; Jan Wohlfahrt; Mads Melbye; Ole Raaschou-Nielsen
Journal:  Int J Cancer       Date:  2011-03-04       Impact factor: 7.396

4.  Increasing Incidence of Testicular Germ Cell Tumors among Racial/Ethnic Minorities in the United States.

Authors:  Armen A Ghazarian; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-08       Impact factor: 4.254

Review 5.  Adolescent and adult risk factors for testicular cancer.

Authors:  Katherine A McGlynn; Britton Trabert
Journal:  Nat Rev Urol       Date:  2012-04-17       Impact factor: 14.432

6.  Childhood height and risk of testicular germ cell tumors in adulthood.

Authors:  Katherine A McGlynn; Jessica L Petrick; Michael Gamborg; Julie Aarestrup; Jennifer L Baker
Journal:  Int J Cancer       Date:  2018-03-26       Impact factor: 7.396

7.  A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility.

Authors:  Peter A Kanetsky; Nandita Mitra; Saran Vardhanabhuti; David J Vaughn; Mingyao Li; Stephanie L Ciosek; Richard Letrero; Kurt D'Andrea; Madhavi Vaddi; David R Doody; Joellen Weaver; Chu Chen; Jacqueline R Starr; Håkon Håkonarson; Daniel J Rader; Andrew K Godwin; Muredach P Reilly; Stephen M Schwartz; Katherine L Nathanson
Journal:  Hum Mol Genet       Date:  2011-05-06       Impact factor: 6.150

Review 8.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

9.  Incidence of testicular germ cell tumors among US men by census region.

Authors:  Armen A Ghazarian; Britton Trabert; Barry I Graubard; Stephen M Schwartz; Sean F Altekruse; Katherine A McGlynn
Journal:  Cancer       Date:  2015-08-17       Impact factor: 6.860

10.  Family history of cancer and malignant germ cell tumors in children: a report from the Children's Oncology Group.

Authors:  Jenny N Poynter; Amy H Radzom; Logan G Spector; Susan Puumala; Leslie L Robison; Zhi Chen; Julie A Ross; Xiao-Ou Shu
Journal:  Cancer Causes Control       Date:  2009-10-15       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.